Lind Kevin Robert's Ownership Disclosure for Avalo Therapeutics, Inc.

The filing discloses that Lind Kevin Robert, a director of Avalo Therapeutics, Inc., owns no securities in the company as of October 1, 2025. The report was signed by Donald R. Reynolds via Power of Attorney on October 2, 2025. This is a standard ownership disclosure required for directors of publicly traded companies.